Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH , and dual‐color in situ hybridization-Reference-Cited by-同舟云学术

Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH , and dual‐color in situ hybridization

Published:2016-02-19 Issue:4 Volume:107 Page:536-542
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kanayama Kazuki¹,Imai Hiroshi¹,Yoneda Misao²,Hirokawa Yoshifumi S.¹,Shiraishi Taizo¹

Affiliation:

1. Department of Oncologic Pathology Mie University Graduate School of Medicine TsuJapan

2. Department of Clinical Nutrition Suzuka University of Medical Science Suzuka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12886

Reference35 articles.

1. Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

2. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

3. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer

4. Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

5. Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

2. A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer;British Journal of Cancer;2023-08-05

3. Clinical significance of CD166 and HER-2 in different types of gastric cancer;Clinical and Translational Oncology;2023-08-03

4. Prediction of the Optimal Number of Tumor Blocks for Her2 Assessment in Gastric Carcinoma Resection Specimens: From Clinical Data to Mathematical Model Simulations;2023

5. Dynamic detection of HER2 of circulating tumor cells in patients with gastric carcinoma and its clinical application;Molecular Medicine Reports;2022-03-28